18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 1, 2012, Pages 120-128

  Vos, Fidel J ^a   Donnelly, J Peter ^a   Oyen, Wim J G ^a   Kullberg, Bart Jan ^a   Bleeker Rovers, Chantal P ^a   Blijlevens, Nicole M A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F FDG PET CT; Febrile neutropenia; Invasive fungal disease; Mucosal barrier injury; Neutropenia; Septic thrombophlebitis

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; MYELOABLATIVE AGENT; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CENTRAL VENOUS CATHETER; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST; DIGESTIVE SYSTEM; DISEASE SEVERITY; ESOPHAGUS; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LOW DRUG DOSE; LUNG; MALE; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; STAPHYLOCOCCAL BACTEREMIA; STREPTOCOCCUS MITIS; SYSTEMIC MYCOSIS; BACTEREMIA; BLOOD DISEASE; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; LUNG MYCOSIS; METABOLISM; MIDDLE AGED; NEUTROPENIA; PATHOGENICITY; PATHOLOGY; SCINTISCANNING; STEM CELL TRANSPLANTATION; STREPTOCOCCUS INFECTION; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BACTEREMIA; BIOLOGICAL TRANSPORT; C-REACTIVE PROTEIN; CATHETERIZATION, CENTRAL VENOUS; FEMALE; FLUORODEOXYGLUCOSE F18; HEMATOLOGIC NEOPLASMS; HUMANS; LUNG; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; NEUTROPENIA; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; STEM CELL TRANSPLANTATION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS MITIS;

EID: 84858788656     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1939-1     Document Type: Article

References (36)

1. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
2. Paul M, Yahav D, Fraser A, Leibovici L. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and metaanalysis of randomized controlled trials. J Antimicrob Chemother 2006;57:176-89. (Pubitemid 43160156)
3. Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Am J Med 2000;108:282-9. (Pubitemid 30110456)
4. Blijlevens NMA, Donnelly JP, De Pauw BE. Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. Bone Marrow Transplant 2005;35:707-11. (Pubitemid 40520956)
5. Blijlevens NM, Donnelly JP, DePauw BE. Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2005;36:703-7. (Pubitemid 41518713)
6. Miceli M, Atoui R, Thertulien R, Barlogie B, Annaissie E, Walker R, et al. Deep septic thrombophlebitis: an unrecognized cause of relapsing bacteremia in patients with cancer. J Clin Oncol 2004;22:1529-31. (Pubitemid 41103641)
7. Koolen DA, van Laarhoven HW, Wobbes T, Punt CJ. Single-centre experience with tunnelled central venous catheters in 150 cancer patients. Neth J Med 2002;60:397-401. (Pubitemid 39089357)
8. Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist 2004;9:207-16. (Pubitemid 38452120)
9. Cordonnier C, Buzyn A, Leverger G, Herbrecht R, Hunault M, Leclercq R, et al. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003;36:149-58. (Pubitemid 36143411)
10. Verweij PE, Donnelly JP, van Die CE, Blijlevens NM, Kullberg BJ, de Pauw BE. Improved diagnostics in invasive aspergillosis and systematic monitoring in patients at high risk of infection. Ned Tijdschr Geneeskd 2005;149:561-7. (Pubitemid 40385711)
11. Donnelly JP. Febrile neutropenia: antifungal prophylaxis. Int J Antimicrob Agents 2000;16:127-30.
12. Klastersky J. Empirical antifungal therapy. Int J Antimicrob Agents 2004;23:105-12. (Pubitemid 38175390)
13. Bleeker-Rovers CP, Vos FJ, Wanten GJ, van der Meer JW, Corstens FH, Kullberg BJ, et al. 18F-FDG PET in detecting metastatic infectious disease. J Nucl Med 2005;46:2014-9. (Pubitemid 46657448)
14. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004;31:29-37. (Pubitemid 38133538)
15. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001;32:191-6. (Pubitemid 32524787)
16. Vos FJ, Bleeker-Rovers CP, Sturm PD, Krabbe PF, van Dijk AP, Cuijpers ML, et al. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia. J Nucl Med 2010;51: 1234-40.
17. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 1995;36:1854-61.
18. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80.
19. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002;32:47-59. (Pubitemid 34112942)
20. Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010;37:181-200.
21. Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M. PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Mol Imaging Biol 2010;12:85-8.
22. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-47. (Pubitemid 27020567)
23. Barloon TJ, Galvin JR, Mori M, Stanford W, Gingrich RD. High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms. Chest 1991;99:928-33.
24. Heussel CP, Kauczor HU, Heussel G, Fischer B, Mildenberger P, Thelen M. Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. AJR Am J Roentgenol 1997;169:1347-53. (Pubitemid 27452498)
25. Miceli MH, Jones Jackson LB, Walker RC, Talamo G, Barlogie B, Anaissie EJ. Diagnosis of infection of implantable central venous catheters by [18F]fluorodeoxyglucose positron emission tomography. Nucl Med Commun 2004;25:813-8. (Pubitemid 39099994)
26. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003;124:1210-9. (Pubitemid 36531797)
27. van der Velden WJ, Herbers AH, Feuth T, Schaap NP, Donnelly JP, Blijlevens NM. Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. PLoS One 2010;5:e15156.
28. Salaun PY, Gastinne T, Bodet-Milin C, Campion L, Cambefort P, Moreau A, et al. Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? Eur J Nucl Med Mol Imaging 2009;36:1813-21.
29. Mahfouz T, Miceli MH, Saghafifar F, Stroud S, Jones-Jackson L, Walker R, et al. 18F-Fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J Clin Oncol 2005;23:7857-63. (Pubitemid 46661462)
30. Miceli M, Atoui R, Walker R, Mahfouz T, Mirza N, Diaz J, et al. Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report. J Clin Oncol 2004;22: 1949-56. (Pubitemid 41095188)
31. de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005;32:98-101. (Pubitemid 40142784)
32. Bybel B, Greenberg ID, Paterson J, Ducharme J, Leslie WD. Increased F-18 FDG intestinal uptake in diabetic patients on metformin: a matched case-control analysis. Clin Nucl Med 2011;36:452-6.
33. Lemberg DA, Issenman RM, Cawdron R, Green T, Mernagh J, Skehan SJ, et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2005;11:733-8. (Pubitemid 41271177)
34. O'Brien SN, Blijlevens NM, Mahfouz TH, Anaissie EJ. Infections in patients with hematological cancer: recent developments. Hematology 2003;438-72.
35. Blijlevens NM, Donnelly JP, Yakar D, van Die CE, de Witte T. Determining mucosal barrier injury to the oesophagus using CT scan. Support Care Cancer 2007;15:1105-8. (Pubitemid 47340964)
36. van der Velden WJ, Blijlevens NM, Feuth T, Donnelly JP. Febrile mucositis in haematopoietic SCT recipients. Bone Marrow Transplant 2009;43:55-60.